L’Oréal USA has inked a partnership with 3-D bioprinting company, Inc. Developed between L’Oréal’s US-based global Technology Incubator and Organovo, the collaboration will leverage Organovo’s proprietary NovoGen Bioprinting Platform and L’Oréal’s expertise in skin engineering to develop 3-D printed skin tissue for product evaluation and other areas of advanced research. Organovo’s 3-D bioprinting enables the reproducible, automated creation of living human tissues that mimic the form and fun...